chlorothiazide sodium
NDC 25021-305, chlorothiazide sodium, injection, powder, lyophilized, for solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-305
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202462
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-305 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLOROTHIAZIDE SODIUM500 mg/18mL
Pharmacologic classes
Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-305-20 | 25021030520 | 1 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL |
| 25021-305-66 | 25021030566 | 1 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=25021-305Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-305
Use it
Look up 25021-305 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-305 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-305. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.